Skip to main content
HCPCS Q5172 · Level II · Part B drug

Q5172: filgrastim-laha (Filkri), HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: OPPS Addendum B: October 2026 (effective October 1, 2026); OPPS NDC-HCPCS crosswalk: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q5172

Billing unit
1 MCG
Inj, filkri, 1 mcg
OPPS payment rate
$0.74
no ASP limit; SI K, October 2026
Practitioner MUE
none published
CMS publishes no MUE for this code
OPPS status
SI K
APC 0973
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS Q5172 is the Level II code for Injection, filgrastim-laha (filkri), biosimilar, 1 microgram, billed per 1 MCG. CMS publishes no ASP payment limit for it; hospital outpatient departments are paid separately under OPPS (status indicator K, $0.74 per billing unit in October 2026). As a biosimilar it has its own code and ASP; the reference product cannot be billed under this code, and the JZ or JW modifier rules for discarded amounts apply per single-dose vial. Other HCPCS codes whose descriptor names filgrastim: Q5148 (biosimilar filgrastim-txid (Nypozi)); Q5125 (biosimilar filgrastim-ayow (Releuko) from Amneal Pharmaceuticals, LLC); Q5110 (biosimilar filgrastim-aafi (Nivestym) from Pfizer Inc); Q5101 (biosimilar filgrastim-sndz (Zarxio) from Sandoz Inc); J1442 (non-biosimilar filgrastim (Neupogen) from Amgen Inc). The OPPS crosswalk maps 1 NDC to it, sold as Filkri by Accord BioPharma, Inc. No current Billing and Coding Article lists Q5172, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare payment: OPPS rate (no ASP limit)

Q5172 does not appear in the October 2026 Part B ASP payment limit file. CMS pays it separately to hospital outpatient departments under OPPS with status indicator K in APC 0973, at a national unadjusted rate of $0.74 per 1 MCG. Status K is a separately paid, non-pass-through drug or biological, including therapeutic radiopharmaceuticals. In a physician office the Medicare contractor prices the drug, often from invoice; commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 OPPS crosswalk maps 1 NDC from 1 labeler to Q5172. Report the NDC in the claim's drug segment and bill the number of Q5172 units that equals the quantity administered divided by 1 MCG; the last column gives units per full package.

NDCs that crosswalk to Q5172
NDCDrug nameLabelerPackage sizeBilling units / package
69448-0008-63FilkriAccord BioPharma, Inc0.5 × 1300

Medically Unlikely Edits (MUE)

CMS does not publish an MUE for Q5172 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.

MUE for Q5172 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists Q5172 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check Q5172 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q5172 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists Q5172 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q5172 carries status indicator K and is assigned to APC 0973, with a published national unadjusted payment of $0.74. Status K means the drug is paid separately under OPPS rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), Q5172 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $0.74 per 1 MCG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for Q5172 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for Q5172

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS Q5172

What does HCPCS code Q5172 describe?

Q5172 is defined by CMS as "Injection, filgrastim-laha (filkri), biosimilar, 1 microgram". Each billing unit represents 1 MCG, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q5172 a CPT code?

No. Q5172 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as filgrastim-laha (Filkri); CPT codes are five-character codes maintained by the AMA. On a Part B claim Q5172 reports the drug itself in 1 mcg units, and the administration is billed on its own line.

What does Medicare pay for Q5172 in a hospital outpatient department?

Q5172 has no Part B ASP limit; the October 2026 OPPS Addendum B pays it separately under status K, APC 0973, at $0.74 per 1 MCG, and ASC Addendum BB gives it payment indicator K2 at $0.74.

Which NDCs map to Q5172?

The October 2026 OPPS crosswalk lists 1 NDC from 1 labeler: Filkri (Accord BioPharma, Inc). For example NDC 69448-0008-63 (package size 0.5) equals 300 billing units of Q5172.

Does Q5172 have NCCI bundling edits?

No active practitioner PTP pairs list Q5172 as a column-1 or column-2 code in the v323r0 release.

Q5172 vs Q5148: what is the difference?

Both are HCPCS Level II codes whose descriptor names filgrastim. What sets Q5148 apart: biosimilar filgrastim-txid (Nypozi). Q5172 is billed per 1 mcg, OPPS rate $0.74; Q5148 is billed per 1 mcg, limit $1.026, MUE 1500. Report the code whose descriptor matches the product and setting in the record.

Q5172 vs Q5125: what is the difference?

Both are HCPCS Level II codes whose descriptor names filgrastim. What sets Q5125 apart: biosimilar filgrastim-ayow (Releuko) from Amneal Pharmaceuticals, LLC. Q5172 is billed per 1 mcg, OPPS rate $0.74; Q5125 is billed per 1 mcg, limit $0.308, MUE 1800. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.